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Introduction
For more than two decades now, there is a constant and 
increasing interest in obtaining bulk amounts of natural 
polyphenolics from the stilbenoid series. namely, in the 
recent years, hundreds of papers report the major biological 
properties of resveratrol. this monomer building block of 
the series is described, among others, as a powerful antioxi-
dant [1], anti-cancer [2] and anti-inflammatory [3] agent. 
not only resveratrol itself, but more recently, some of its 
derivatives (monomers and oligomers) were shown to have 
interesting pharmacological properties. this is the case, for 
instance, of the inhibitory effects on tyrosinase activity of 
oxyresveratrol [4].
Indeed, since back to the 1990s, the “wooden” part of 
vine is known by us to be one of the most valuable natural 
sources of stilbenoids: the two major occurring constitu-
ents being the monomer trans-resveratrol 1, and one of its 
dimers, (+)-trans-ε-viniferin 2 (Fig. 1).
In order to identify the richest stalks from various red 
and white grape varieties (cépages), we prepared specific 
polyphenolic extracts. Chromatographic dosages (hPLC 
analysis) of the many crude extract solutions allowed us 
to observe an unprecedented phenomenon: for instance, 
in reiterated analysis of one same extract, 2 was detected 
in either more than 20 % yields or totally absent (0 %)! 
trying to understand such unpredictable results, we 
could evidence that these discrepencies originated from 
the type of the syringe filter used to filtrate the analyzed 
samples.
We then wondered if this behaviour, crucial at a very 
small scale (filtration of very diluted solutions), could be 
transposed to “gram scale” of crude Vitis vinifera stalks 
extracts and could lead to preparative amounts of enriched 
fractions or of pure either 1 or 2. the large amounts of 
Abstract repeated chromatographic analyses of poly-
phenolic vine stalks extracts allowed us to note a huge 
adsorption difference on polyvinylidene fluoride (PVDF), 
between trans-resveratrol 1 and (+)-trans-ε-viniferin 2. 
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amounts of these two pure compounds, they were tested 
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the most powerful tyrosinase inhibitor, among all samples 
tested.
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these two stilbenoids provided by this process would give 




the polyvinylidene fluoride (PVDF) is a commercial poly-
mer (alfa aesar, a Johnson mattley Company, Ward hill, 
ma), with a density = 0.38 and is used as it is. trans-res-
veratrol 1 [or (E)-5-(4-hydroxystyryl)benzene-1,3-diol] 
and (+)-trans-ε-viniferin 2 {or 5-[(2S, 3S)-6-hydroxy-2-
(4-hydroxyphenyl)-4-(4-hydroxystyryl)-2,3-dihydroben-
zofuran-3-yl]benzene-1,3-diol} obtained through the 
described process were authenticated by hPLC chromato-
grams comparison with homemade authentic sample ref-
erences and of their 1h nmr (500 mhz) spectra. mush-
room tyrosinase (E.C. 1.14.18.1, t3824 Sigma, 25,000 
units mg−1), l-DOPa (L0400000 Fluka, crystalline), kojic 
acid (K3125 Sigma, crystalline 100 % purity), ascorbic 
acid (a1300000 Fluka, crystalline 100 % purity), arbutin 
(a4256 Sigma, ≥98 % purity) and mushroom tyrosinase 
were purchased from Sigma-aldrich, Saint-Quentin Fal-
lavier France. acetone, ethanol, acetonitrile (hPLC grade) 
and ethyl acetate are from Labover, montpellier, France. 
all solvents were rectified prior to be used.
hPLC analyses
hPLC analyses of the extracts were performed using a 
liquid chromatograph model 2695 from Waters (Guyan-
court, France) connected to a dual absorbance detector 
(model 2487), monitored at 330 nm, and equipped with a 
Synergi 4 μm hydro rP 80a column (250 × 2.0 mm I.D., 
4 μm particle size, Phenomenex, Le Pecq, France) and 
with a guard cartridge of the same material. the mobile 
phase was composed of two solvents: solvent a = water 
with 0.015 % h3PO4 (v/v) and solvent B = Ch3Cn, at a 
flow rate of 0.2 mL min−1 with the following gradient: 
32–50 % B (0–20 min), 50 % B (20–25 min), 50–100 % B 
(25–29 min) and 100 % B (29–45 min). Each 2 mL oligom-
ers of resveratrol (Or) sample (0.25 mg mL−1) solution in 
the same solvent as the starting gradient (solvent a = 68 % 
and solvent B = 32 %; v/v), was filtrated through a dispos-
able syringe filter, pore size 0.45 µm from macherey–nagel 
(hoerd, France), either of PEt-type (Chromafil® Xtra PEt-
45/25-Polyester), or of PVDF-type (Chromafil® P-45/25-
PVDF), prior to be injected (10 μL) from the autosampler. 
amounts of 1 and 2 in each injected sample were calculated 
by using individual calibration curves for peaks at retention 
times of 9.2 and 13.5 min, for 1 and 2, respectively.
Enrichment Process
Preparation of crude stilbenoid extracts (oligomers of 
resveratrol = Or): Or extracts are obtained from finely 
powdered stalks of V. vinifera, following the process 
described in [5]. Vine shoots, harvested every year during 
winter pruning, are selected according to their richness in 
stilbenoids (highest concentrations are found in different 
“cépages”, depending on the year). In this study, crude Or 
extract from “merlot noir” stalks (Ormn) used to set up 
the conditions for the enrichment process, contained ini-
tially 12.4 % of 1 and 15.8 % of 2 (w/w).
Preparation of the PVDF support: the PVDF 
(500 g = 1.3 L) is stirred in a 5 L flask, for 2 h at room tem-
perature, with 2 L of acetone–water (4:96; v/v = the cho-
sen solvent a used to set up the conditions for the enrich-
ment process), in order to moisten it. the thus “prepared 
support” is considered to be “ready to use”, after removal 
of the excess of solvent by filtration.
adsorption step = obtention of the trans-resveratrol 1 
enriched fraction: the solution of 10 g of Ormn in 1 L of 
the chosen solvent a is added to the flask containing the 
500 g prepared PVDF. the resulting slurry is stirred for 
15 min, before to be filtered. the support is rinsed with 1 L 
of chosen solvent a, in three times. the different filtrates 
are pooled and concentrated by evaporation in vacuo at 
room temperature of the organic phase. the residual aque-
ous solution is freeze-dried to yield 5.7 g of fraction 1. 
analyzed by hPLC, without any filtration, it was shown to 
contain 736 mg of 1 and 407.8 mg of 2.
Desorption step = obtention of the 2 enriched fraction: 
the support is then shaken for 15 min with 1 L of the sol-
vent B chosen to set up the conditions for the enrichment 
process (acetone–water 80:20; v/v), before filtration. this 
operation was repeated once. the two filtrates are pooled 
and concentrated by evaporation in vacuo to get rid of the 
organic phase. the resulting aqueous solution is freeze-
dried to furnish the fraction 2 (2.56 g): analyzed by hPLC, 
without preliminary filtration, it was shown to contain 
142 mg of 1 and 645 mg of 2.
Fig. 1  Chemical structures of trans-resveratrol 1 and trans-ε-viniferin 2
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measurement of tyrosinase Inhibition activity
Conditions used: the conditions used to measure the capac-
ity of each compound to inhibit tyrosinase l-DOPa oxidase 
activity were adapted from Kang [6]. 40 μL of phosphate 
buffer (=control; 67 mm, ph 6.8) or of solutions of 1 (25, 
50, 125, 250 and 500 μm), 2 (6.5, 13, 26, 52 and 104 μm), 
kojic acid (12.7, 25, 51, 127 and 254 μm), arbutin (63, 
127, 254, 507 and 1014 μm), or ascorbic acid (100, 200, 
400, 1000 and 2000 μm) in phosphate buffer are added to 
40 μL of mushroom tyrosinase (248 u/mL) and incubated 
at 37 °C for 30 min in a 96-well microplate. then, 40 μL 
l-DOPa (2.5 mm) and 80 μL phosphate buffer were added 
to the solution. Optical density (OD) of each assay, relative 
to the control, was measured at 492 nm by using a micro-
plate reader (tecan® Infinite m200 spectrophotometer).
results expression: Inhibition of enzyme activity by 
each sample is expressed as  % inhibition compared to 
the control and represented by the following equation: 
[1 − (ODsample × OD−1control)] × 100.
Results and Discussion
Observation of an unexpected Phenomenon
Looking for the red or white grape varieties (cépages) with 
the highest stilbenoids content, we were dosing 1 and 2 by 
hPLC–uV. 10 μL of the solution (0.25 mg mL−1) of each 
stalk extract [5], in the mixture of 0.015 % h3PO4 (v/v) in 
water and 32 % Ch3Cn (v/v), was injected in triplicates, 
on the column after filtration on a disposable syringe filter. 
In such conditions, concentrations of 2 were ranging from 
25 to 0 %. We were fully confident with the results, because 
there was a good repeatability between the triplicates (SD 
mean ≤0.1 %), until a major difference appeared between 
two measurements of the same extract: the two first values 
were speaking for 16.9 ± 0.06 % of 2, and 13.4 ± 0.01 % 
of 1, while the third one for 0 % of 2, and 13.5 % of 1 
(Fig. 2).
rapidly, we found that this huge difference was due 
to the membrane type of the syringe filter used to “pre-
pare” the solutions before injection: the two first values 
(16.9 ± 0.06 % of 2) were obtained when using a polyeth-
ylene terephthalate (PEt) filter (Fig. 2b), while the last one 
(0 % of 2, arrow Fig. 2c) resulted from a polyvinylidene 
fluoride (PVDF) filter.
recommendation to the Phytochemists
It is of general practice to pass sample solutions through 
filters, for hPLC analysis. While previous reports have 
already mentioned that, depending on the nature of the 
membrane polymer, adsorption of polyphenols, in general, 
is a major issue for fouling the filters during microfiltration 
of wine [7] and even, specifically, that PVDF filters should 
not be used with resveratrol and its monomeric derivatives 
since they are adsorbed onto [8], it is the first time here 
that such a difference of adsorption on PVDF is observed 
between the monomer 1 and one of its dimer 2. thus, it is 
of prime importance to let phytochemists involved in the 
study of plant metabolites of the stilbenoid series know that 
such a filter would not allow to get to their true composi-
tion. the only way to ensure that the filter has no impact 
on the analyses is to run an analysis without filtration 
(Fig. 2a). to have reliable dosages of stilbenoids, PVDF 
Fig. 2  Chromatographic pro-
files of the same crude stalk stil-
benoid extract (Or) measured 
at 330 nm: a without filtration, 
b filtration on a PEt filter, and c 
filtration on a PVDF filter
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membrane filters must be avoided. Possibly, this could have 
led to erroneous results in the past, as it was most prob-
ably the case, in the mazza’s study: these authors precised 
the use of PVDF membrane filters before hPLC injections 
[9], aiming at assessing the amounts of 1 and 2 contained in 
grape cane waste. also, because PVDF, chemically “inert”, 
durable and biocompatible, is widely used in food and 
medicinal applications for ultra- or micro-filtration [10], 
this information should be extended to those fields.
Enrichment Process
an Ormn extract, containing initially 12.4 % of 1 and 
15.8 % of 2 (w/w) was used to set up the conditions for the 
enrichment process. the PVDF capacity to adsorb 2 during 
filtration of sample solutions to be analyzed by hPLC, was 
clearly shown to be limited: the peak of 2 at 13.5 min in 
the chromatogram, after having disappeared completely, is 
growing up, then, depending on the concentration or on the 
volume of the filtered solution. this capacity was measured 
first and the w/w ratio optimized to be able to treat “grams” 
of crude extracts: 500 g of PVDF for 10 g of Ormn extract 
containing 1.58 g of 2. the enrichment process includes at 
least one cycle of adsorption–desorption onto the PVDF 
support.
adsorption step: the much more efficient adsorption of 
2 compared to 1 onto the perfluorinated polymer has some-
thing to see with the peculiar dimeric structure. the solvent 
for this step (solvent a) must be chosen to be capable to 
solubilize all the constituents of the Or extracts, but the 
minimum of 2 in the presence of PVDF. this solvent is—in 
particular—a monophasic mixture of water and acetoni-
trile, acetone or methanol, in which the water represents 
from 99.8 % to at least 70 % (v/v). In the present case, we 
have used 1 L of acetone–water (4:96; v/v). adsorption is 
facilitated by moistening the PVDF support, in the pres-
ence of the solvent a. the resulting slurry is stirred for 
15 min, to allow selective adsorption of 2 onto the PVDF. 
During this first step of the process, 2 is adsorbed onto the 
PVDF, while 1 mainly keeps in solution. the slurry is fil-
trated and the support is rinsed two times by the same sol-
vent a. the different filtrates are pooled prior to be con-
centrated by evaporation in vacuo of the organic part. the 
residual aqueous solution is freeze-dried to yield fraction 1, 
enriched in 1.
Desorption step: then, trans-ε-viniferin 2 is desorbed 
from the support by an ideal solvent, to obtain a solution 
enriched in 2. to insure an efficient desorption of 2 from 
the support, the elution solvent (solvent B) must also be a 
monophasic mixture of water and an organic solvent, but 
containing now, a larger proportion of the latter. It is, for 
example, a mixture of acetonitrile–water (95:5; v/v), ace-
tone–water (90:10; v/v) or methanol–water (50:50; v/v). In 
the present case, we have used acetone–water (80:20; v/v). 
this step is realized by stirring the adsorbed-support with 
the chosen solvent B, followed by filtration. this desorp-
tion step is repeated twice, and the two fractions are com-
bined prior to the evaporation under reduced pressure of 
the organic solvent. the resulting concentrated aqueous 
solution is freeze-dried to give the fraction 2, enriched in 
(+)-trans-ε-viniferin 2.
Enrichment data: By submitting 10 g of the Ormn 
extract with a 1 to 2 starting ratio of 0.78 and a 2 to 1 ratio 
of 1.28 (all the proportions of 1 and 2 being expressed 
in w/w), to one cycle of this process, in the conditions 
described in this section, we have obtained 5.7 g of a frac-
tion 1 (12.9 % in 1 and 7.2 % in 2) with a 1–2 ratio of 1.79, 
enriched 2.3 times in 1, and 2.56 g of a fraction 2 (5.5 % 
in 1 and 25.1 % in 2) with a 2–1 ratio of 4.56, enriched 3.6 
times in 2 (Fig. 3).
By repeating this process to a suitable enriched fraction, 
it is possible to enrich further the fraction in either 1 or 2. 
unfortunately, each cycle of this very fast and easy process 
is accompanied by an important loss of material: at least 
29 % (w/w) in 1, and 33.6 % (w/w) in 2.
Comparison with other process: Several processes 
have already described [11, 12] the separation of 
Fig. 3  Enrichments in 1 and 2 obtained with one cycle of the process 
from Ormn extract
Table 1  Summary of the tyrosinase inhibition of compounds 1, 2 and 
of other known compounds
IC50 values represent the concentration of sample causing 50 % inhi-
bition of tyrosinase
Each value represents the mean ± SD of three experiments
IC50 (μm) activity ratio 
against 2
trans-ε-Viniferin 2 4.1 ± 0.5 1
Kojic acid 16.9 ± 1.1 1/4.1
trans-resveratrol 1 52.8 ± 1.4 1/12.9
arbutin 55.1 ± 8.9 1/13.4
ascorbic acid 255 ± 10 1/62.2
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trans-resveratrol and trans-ε-viniferin from crude extracts. 
Our process relies on the observation that a big difference 
of adsorption on PVDF exists between monomer 1 and one 
of its dimer 2. to the best of our knowledge, it is the first 
time that PVDF “powder” is used as a support to enrich 
fractions in either ones of those compounds from V. vinif-
era stalk extracts [13].
tyrosinase inhibition effect: having at hands pure 1 and 
pure 2, we examined some of their biological properties. 
In this study, we report on the tyrosinase inhibitory effects 
of these two compounds, with respect to the second step 
of tyrosinase oxidation [14] (l-DOPa oxidase). the most 
potent 2, was then compared to other references such as 
arbutin, kojic or ascorbic acids, frequently used for cos-
metic purpose as anti-tyrosinase (table 1).
mushroom tyrosinase was chosen to run these experi-
ments, as it is classically used to detect and develop 
tyrosinase inhibitors [15]. the present study estab-
lished that kojic acid inhibits the enzyme very effectively 
(IC50 = 16.9 μm). however, compound 2 clearly revealed 
to be the most active tyrosinase inhibitor ever tested by 
us, with an IC50 = 4.1 μm (table 1). thus, (+)-trans-
ε-viniferin 2 is more than four times more potent than 
kojic acid (IC50 = 16.9 μm), and 62-fold more active 
than ascorbic acid (IC50 = 255 μm) to inhibit tyrosinase 
(table 1). trans-resveratrol 1 has a moderate inhibi-
tory activity (IC50 = 52.8 μm), quite similar to arbutin 
(IC50 = 55.1 μm).
Conclusions
Because PVDF polymer was shown to adsorb selectively 
and very efficiently 2 from a solution, while 1 mainly 
keeps in solution, phytochemists using hPLC as an analyti-
cal tool, should keep in mind that the choice of the mem-
brane filter for samples preparation is crucial to get reliable 
results, at least with such stilbenoids. taking advantage of 
this information, and because PVDF polymer is very stable, 
abundant, and cheap, we developed a simple, inexpensive 
and a preparative scale purification process of 1 and of 2 
from the crude extracts of V. vinifera stalks. as a pure com-
pound, 2 can therefore be easily sterilized and becomes 
potentially a useful active ingredient to treat melanosis or 
most of the other melanin overproduction disorders (mel-
anoma), as well as a skin-lightening agent (against dark 
spots in dermatocosmetics, for instance).
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